Speakers Bureau

Faculty willing to give educational talks in Boston and surrounding communities about prevention, brain health, warning signs for Alzheimer’s disease and opportunities for clinical trials.

Bernard Hanseeuw, M.D., Ph.D.

Behavioral Neurologist, Massachusetts General Hospital

Additional Languages Spoken: French, English, Spanish, Dutch

Bernard Hanseeuw is a behavioral neurologist. He obtained his MD, PhD in Belgium before moving to Boston. Since September 2014, he works as a postdoctoral research fellow at Massachusetts General Hospital. His research intends to understand the relationships between brain pathologies and cognitive deficits in normal aging and age-related disease, with a special focus on early detection of Alzheimer's disease. He has a special interest in brain imaging, particularly in amyloid, tau, and other PET imaging techniques. He aims to offer better care to patients with or at-risk for memory decline, and help the search of a cure, to keep longer the most precious gift we all have: our brain.

Bradley T. Hyman, M.D., Ph.D

Director, Massachusetts Alzheimer's Disease Research Center
John B. Penney Jr. Professor of Neurology, Harvard Medical School

Brad Hyman is the John B. Penny, Jr. Professor of Neurology at Harvard Medical School. He directs the Alzheimer’s unit at Mass General Institute for Neurological Disease (MIND), with the goal of understanding the neuropathophysiologic and genetic factors that underlie dementia. Dr. Hyman’s laboratory studies the anatomical and molecular basis of dementia in Alzheimer’s disease and dementia with Lewy bodies.

Dr. Hyman received his M.D. and Ph.D. from University of Iowa, and he has received the Metropolitan Life Award, the Potamkin Prize, an NIH Merit award, and an Alzheimer’s Association Pioneer Award. He is the current director of the Massachusetts Alzheimer’s Disease Research Center. 

Lenore Jackson-Pope, RN, BSN, MSM, CCRP

Co-Director of Primary Care Outreach
Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital
Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital

Lenore is the Co-Director of Primary Care Outreach at the Center for Alzheimer Research and Treatment and the Massachusetts Alzheimer’s Disease Research Center. She is instrumental in educating primary care physicians about the warning signs of Alzheimer’s disease and direct referral networks. Lenore is the former Manager of Research and Medical Education at the Massachusetts/New Hampshire Chapter of the Alzheimer’s Association, and has supported clinical research operations for over 30 years. She is an Adjunct Faculty Member at Emmanuel College in the Graduate and Professionals Management Program, and a registered nurse who has worked in both acute and long-term care settings. Lenore is passionate about the importance of clinical trial participation and is forever grateful to the many wonderful research volunteers she has been privileged to work with over the years.

Judith Johanson

Clinical Research Ambassador for Massachusetts Alzheimer’s Disease Research Center at Massachusetts General Hospital

Alzheimer’s Association MA/NH Chapter Board Member and Public Policy Advocate

National Speaker, Advocate and Champion on Caregiver Issues


Judy is an experienced caregiver and advocate, who developed, along with her family a positive and collaborative approach to caregiving for her late husband, Steve. Steve lived with Early Onset Alzheimer's Disease for over six years. Judy has supported many others fighting  Alzheimer’s disease, including her mother-in-law and families she has met through her affiliation with the Alzheimer's AssociationShe has become a major contributor in the development of educational programs, most recently helping health care providers in acute care settings better understand the needs of patients and families dealing with dementia. Judy is a Standard of Excellence Council Member for National Institute for Dementia Education.

Judy collaborated with her husband Steve to create a call to action for improvements in care, support and funding for research. Together, Judy and Steve became passionate advocates and helped change how others look at the life of individuals and families living with Alzheimer's Disease. They fought locally and nationally for increases in research funding and for improvements in health care for those living with dementia.  Judy and Steve's partnership during their journey modeled the importance of honest communication and positive messaging, focusing on managing symptoms of Alzheimer’s disease and developing creative approaches to caring for those living with the disease. Their work highlighted the importance of continued engagement in the face of devastating news, inspiring others to become advocates and share their journeys. Together they created a legacy to live on long after Steve’s passing. Judy continues to share her successful (and not so successful) strategies in her role at the Massachusetts Alzheimer's Disease Research Center, in the hope of demystifying and reducing the stigma of Alzheimer's Disease and other related dementias. Judy is currently developing a program called “Road Map to Caregiving.” Her goal is to inspire fellow caregivers and expand their “tool box” of resources, so that they don’t’ have to travel the arduous journey through Alzheimer’s alone.

Cynthia A. Lemere, Ph.D.

Scientist, Ann Romney Center for Neurologic Diseases, Brigham & Women's Hospital
Associate Professor of Neurology, Harvard Medical School

Dr. Lemere focuses on translational research for understanding, preventing and treating Alzheimer's disease. Dr. Lemere earned a bachelor’s degree in Psychology and Education from Mount Holyoke College and a master’s in Neurobiology from SUNY Albany. Dr. Lemere examined Alzheimer's-related brain changes in people with Down syndrome in the Selkoe Laboratory at Brigham and Women's Hospital while pursuing her doctorate in Pathology at Boston University School of Medicine. After receiving her Ph.D., she remained at the Center as a Postdoctoral Research Fellow, Instructor, Assistant Professor and is currently an Associate Professor in the Department of Neurology. Her current research involves: a) preclinical studies of antibody-treatments and vaccines, with and without focused ultrasound treatments, to reduce a disease-relevant form of the amyloid-beta protein that accumulates and forms plaques in the Alzheimer’s brain; b) the role of the body’s immune host-defense system (e.g., complement) in Alzheimer’s disease progression; and, c) the effects of deep space galactic cosmic radiation on brain aging and the risk of Alzheimer’s in preparation for NASA’s first manned mission to Mars in the 2030s. Dr. Lemere participates in local and national mentoring programs for underrepresented minorities including high school, undergraduate and medical students. Dr. Lemere serves on several national and international scientific advisory boards, including the National Alzheimer’s Association Medical and Scientific Advisory Council, the Dominantly Inherited Alzheimer’s Network Therapeutic Unit (DIAN-TU) Therapeutic Evaluation Committee, the International Alzheimer’s Disease/Parkinson’s Disease (ADPD) Conference Scientific Advisory Council, the BrightFocus Foundation Scientific Review Council and the DownSyndrome Achieves Biobank Governing Board of Directors. In addition, she serves as a scientific advisor for several companies

Gad A. Marshall. M.D.

Associate Medical Director of Clinical Trials, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Massachusetts General Hospital
Assistant Professor of Neurology, Harvard Medical School

Gad Marshall is board certified in Neurology. He is currently the Associate Medical Director of Clinical Trials at the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital; Associate Neurologist at Brigham and Women’s Hospital; Assistant in Neurology at Massachusetts General Hospital; and Assistant Professor of Neurology at Harvard Medical School. Dr. Marshall has been site principal investigator for multiple clinical trials of amyloid-modifying drugs in Alzheimer’s disease and is currently the site principal investigator for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) 3, DoD-ADNI, and the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) trial. His research has focused on clinical correlates of activities of daily living and neuropsychiatric symptoms with multiple imaging markers and cerebrospinal fluid biomarkers across the early Alzheimer’s disease spectrum, as well as developing novel, sensitive, and ecologically-valid assessments for early functional changes in Alzheimer's disease.

Scott McGinnis, M.D.

Assistant Professor of Neurology, Harvard Medical School

Scott McGinnis is a a behavioral neurologist at the BWH Center for Brain Mind Medicine, an investigator in the BWH Center for Alzheimer Research and Treatment and an investigator in the MGH Frontotemporal Disorders Unit. He completed his residency in neurology in the MGH/BWH program and a fellowship in behavioral neurology and neuropsychiatry at BWH. Dr. McGinnis’ career comprises patient care, education of students, residents, and fellows, and clinical research studies on aging and neurodegenerative dementias. His research interests include atypical presentations of Alzheimer disease and non-Alzheimer cognitive neurodegenerative disorders.

Alison J. McManus N.P.

Dr. McManus is board certified as a Family Nurse Practitioner and Principal Investigator within the Department of Neurology at Massachusetts General Hospital (MGH).  Dr. McManus graduated as a Registered Nurse in 1987 and subsequently became Certified in both Intensive Care and Emergency Nursing.  She received an MSN as a Family Nurse Practitioner from the University of San Diego and a Doctorate in Nursing Practice from Rush University in Chicago. 

Dr McManus is the Clinical Research Nurse Manager of the Alzheimer’s Clinical & Translational Research Unit (ACTRU) at MGH.  Her work broadly involves the management of translational and clinical trial activities at the ACTRU.   She supervises the conduct of sponsor and investigator-initiated trials, as well as the clinical care of patients enrolled in clinical research projects, within the ACTRU.  Dr McManus is one of only a handful of Nurse Practitioners in the nation who are leading these types of clinical drug trials as a Principal Investigator.

Martha Muniz

Martha received her Bachelor of Arts in Psychology (’08) and Master of Arts in Psychology (’12) degrees from San Diego State University and Boston University, respectively. She has worked in public health research (Hispanic Community Health Study/Study of Latinos), aging and Alzheimer’s disease research at the University of California (San Diego), and has been a research coordinator at the Harvard Aging Brain study (HABS) since 2016. Currently, she assists in data collection, outreach efforts, and coordinates the newly funded Spanish speaking cohort of HABS. She is excited to continue learning about aging and cognition in older adults within and outside the Latino community.

Margaret O'Connor, Ph.D

Margaret O’Connor, Ph.D./ABPP is President Elect of the International Neuropsychological Society a scientific and educational organization dedicated to enhancing the international and interdisciplinary study of brain-behavioral relationships.  She has held leadership positions as Co-Chair of the Medical and Scientific Advisory Committee of the Alzheimer’s Association of Massachusetts and New Hampshire and in the Austism/Aspergers Network.  Dr. O’Connor is an Associate Professor of Neurology at Harvard Medical School. She has diplomate status in the field of clinical neuropsychology since 1999 and she is a board examiner for the American Academy of Clinical Neuropsychology.   She was the Director of Neuropsychology in the Department of Neurology at Beth Israel Deaconess Medical Center between 1994 and 2018. In her role as director of a busy clinical service, she was involved in clinical, administrative, and teaching activities. Dr. O’Connor has mentored the clinical and research activities of over 80 graduate students and post-doctoral fellows. She has authored over 65 papers in peer reviewed journals and 30 book chapters. Her work has involved studies of amnesia and long term forgetting with a focus on understanding neural and physiological substrates of memory. She has also focused on pragmatic areas of research relevant to the health and safety of people with dementia. She co-founded DriveWise, a driving assessment program that has provided services for over 900 individuals. In addition to clinical research she developed educational videos to assist professionals and caregivers in making decisions about driving for people with dementia as well as those with developmental disabilities. Dr. O’Connor is actively involved in public education efforts to advance research and clinical support for people with cognitive impairments.